Cargando…

The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain

Low-dose naltrexone (LDN) has been demonstrated to reduce symptom severity in conditions such as fibromyalgia, Crohn’s disease, multiple sclerosis, and complex regional pain syndrome. We review the evidence that LDN may operate as a novel anti-inflammatory agent in the central nervous system, via ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Younger, Jarred, Parkitny, Luke, McLain, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962576/
https://www.ncbi.nlm.nih.gov/pubmed/24526250
http://dx.doi.org/10.1007/s10067-014-2517-2